Mahagaba-M OD Tablet SR
Marketer
Mankind Pharma Ltd
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Mahagaba-M OD Tablet SR
Gabapentin extended-release tablets are a prescription medication indicated for neuropathic pain management. They alleviate pain by regulating nerve cell calcium channel function. This medication also safeguards nerve fibers and facilitates the repair of damaged nerve cells. Gabapentin extended-release tablets are administered orally, with or without food, ideally at bedtime. Consistent daily dosing is recommended to ensure stable drug levels. Adhere strictly to the prescribed dosage and duration, as this medication has the potential for dependence. If a dose is missed, take it as soon as remembered. Complete the entire course of therapy, even with symptom improvement. Abrupt cessation should be avoided without consulting your physician. Commonly reported side effects include upper respiratory infection, increased appetite, elevated mood, trembling, visual disturbances, dry mouth, vertigo, and somnolence. Refrain from operating machinery or engaging in activities requiring concentration until the drug's effects are known. These side effects are generally mild and subside over time. Weight gain may occur; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal ideation to your doctor immediately. Comprehensive disclosure of all other medications being taken is crucial, as interactions may reduce efficacy or alter the medication's action. Inform your physician of pregnancy, pregnancy plans, or breastfeeding.
Uses of Mahagaba-M OD Tablet SR
Managing neuropathic pain
Major Benefits of Mahagaba-M OD Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mahagaba-M OD Tablet SR can be consumed with or without food, though consistent timing is recommended for optimal results.
Common Side effects of Mahagaba-M OD Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Mahagaba-M OD Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Mahagaba-M OD Tablet SR. Ingest the tablet whole; do not break, crush, or chew it. While you can take it with or without food, consistency is key—take it at the same time each day.
How Mahagaba-M OD Tablet SR works:
Mahagaba-M OD Tablet SR combines methylcobalamin, a B vitamin crucial for myelin production (the protective sheath around nerves), and pregabalin, an alpha-2-delta ligand. Methylcobalamin aids in nerve repair and regeneration. Pregabalin's mechanism involves modulating nerve cell calcium channels, reducing pain signals. This synergistic action effectively alleviates neuropathic pain stemming from nerve damage.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Mahagaba-M OD Tablet SR and alcohol may lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Mahagaba-M OD Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Mahagaba-M OD Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving should be avoided if taking Mahagaba-M OD Tablet SR, as it may induce drowsiness, blurred vision, dizziness, and reduced alertness.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Mahagaba-M OD Tablet SR. Dosage modification of Mahagaba-M OD Tablet SR might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Mahagaba-M OD Tablet SR appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary, though further investigation is warranted. Physician consultation is recommended.
What if you forget to take Mahagaba-M OD Tablet SR :
Should you forget a Mahagaba-M OD Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mahagaba-M OD Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Neuroscience, Central Nervous System |



